| Variables | Male (N = 48) | Female (N = 50) | Total | X2 | p Value |
|
| n(%) | N (%) |
|
|
|
| Age groups (years) | |||||
| <20 | 16 (33.3) | 8 (16.0) | 24 (24.5) | 12.869 | 0.025* |
| 20 - 29 | 1 (2.1) | 9 (18.0) | 10 (10.2) |
|
|
| 30 - 39 | 14 (29.2) | 20 (40.0) | 34 (34.7) |
|
|
| 40 - 49 | 14 (29.2) | 8 (16.0) | 22 (22.4) |
|
|
| 50 - 59 | 3 (6.2) | 4 (8.0) | 7 (7.1) |
|
|
| 60 - 69 | 0 (0.0) | 1 (2.0) | 1 (2.0) |
|
|
| Weight (kg) | |||||
| <20 | 8 (16.7) | 4 (8.0) | 12 (12.2) | 14.986 | 0.036* |
| 20 - 29.9 | 5 (10.4) | 2 (4.0) | 7 (7.1) |
|
|
| 30 - 39.9 | 1 (2.1) | 3 (6.0) | 4 (4.1) |
|
|
| 40 - 49.9 | 5 (10.4) | 17 (34.0) | 22 (22.4) |
|
|
| 50 - 59.9 | 15 (31.2) | 14 (28.0) | 29 (29.6) |
|
|
| 60 - 69.9 | 7 (14.6) | 9 (18.0) | 16 (16.3) |
|
|
| 70 - 79.9 | 6 (12.5) | 1 (2.0) | 7 (7.1) |
|
|
| 999 | 1 (2.1) | 0 (0.0) | 1 (1.0) |
|
|
| Residence | |||||
| Urban | 33 (68.8) | 28 (56.0) | 61 (62.2) | 1.694 | 0.193 |
| Rural | 15 (31.2) | 22 (44.0) | 37 (37.8) |
|
|
| Site of disease | |||||
| Pulmonary | 43 (89.6) | 47 (94.0) | 90 (91.8) | 0.637 | 0.425 |
| Extrapulmonary | 5 (10.4) | 3 (6.0) | 8 (8.2) |
|
|
| Sputum AFB status | |||||
| Positive | 17 (36.2) | 19 (38.0) | 36 (37.1) | 3.161 | 0.367 |
| Negative | 18 (38.3) | 25 (50.0) | 43 (44.3) |
|
|
| Unable to produce sputum | 10 (21.3) | 5 (10.0) | 15 (15.5) |
|
|
| Others | 2 (4.3) | 1 (2.0) | 3 (3.1) |
|
|
| Antiretroviral treatment status | |||||
| On treatment | 21 (43.8) | 25 (50.0) | 46 (46.9) | 0.384 | 0.535 |
| Not on treatment | 27 (56.2) | 25 (50.0) | 52 (53.1) |
|
|
| Treatment Regimen | |||||
| Category 1 | 46 (95.8) | 48 (96.0) | 94 (95.9) | 0.002 | 0.967 |
| Category 2 | 2 (4.2) | 2 (4.0) | 4 (4.1) |
|
|